How should peritoneal fluid be evaluated and managed, including appropriate diagnostic tests and treatment thresholds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Peritoneal Fluid Evaluation and Management

All patients with cirrhosis and new-onset ascites or those hospitalized with ascites-related symptoms should undergo diagnostic paracentesis immediately, with testing for serum-ascites albumin gradient (SAAG), cell count with differential, Gram stain, and culture 1.

Diagnostic Paracentesis: When and What to Test

Timing and Indications

  • Perform paracentesis within 12-24 hours of hospital admission for all cirrhotic patients with ascites, as this timing is associated with lower hospital mortality 1
  • Even asymptomatic patients require testing due to high risk of spontaneous bacterial peritonitis (SBP)
  • First episode of ascites (outpatient): Test SAAG, PMN count, and protein concentration 2
  • Recurrent ascites (inpatient): Test PMN count and culture only 2

Essential Tests - The Basic Profile

SAAG (Serum-Ascites Albumin Gradient):

  • Calculate by subtracting ascitic fluid albumin from serum albumin
  • SAAG ≥1.1 g/dL indicates portal hypertension with 97% accuracy 2
  • SAAG <1.1 g/dL suggests non-portal hypertension causes (peritoneal carcinomatosis, tuberculosis) 2
  • Cardiac ascites typically shows SAAG ≥1.1 g/dL AND high ascitic protein >2.5 g/dL 1, 2

Cell Count with Differential:

  • SBP is diagnosed when PMN count exceeds 250/mm³, regardless of culture results 1
  • PMN count >250/mm³ has a likelihood ratio of 6.4 for SBP 3
  • PMN count ≤250/mm³ has a likelihood ratio of 0.2, effectively ruling out SBP 3
  • Automated cell counting is reliable and should be performed in body fluid mode (not urine mode, which shows interference) 4, 5

Culture:

  • Inoculate blood culture bottles at bedside immediately - this increases diagnostic yield from 77% to 100% compared to delayed inoculation 3
  • This is the single most important technical factor for culture success

Additional Tests - Context-Specific

Order these only when clinically indicated 2, 6:

  • Glucose and LDH: When secondary bacterial peritonitis is suspected (to differentiate from SBP)
  • Total protein: For primary SBP prophylaxis decisions or when cardiac ascites is suspected
  • Amylase: Only when pancreatic ascites is suspected
  • Bilirubin: When choleperitoneum is suspected
  • Triglycerides: To differentiate chylous from pseudochylous ascites
  • Creatinine: To detect intraperitoneal urinary leakage
  • Cytology: Only when malignancy or non-cirrhotic causes are suspected

Management Algorithm

Initial Ascites Management (Cirrhosis)

  1. Sodium restriction to 2000 mg/day with dietician consultation 1

  2. Start combined diuretics immediately:

    • Spironolactone 100 mg once daily (morning dose to avoid nocturia)
    • Furosemide 40 mg daily
    • The 40:100 ratio maintains normokalemia and outperforms monotherapy 1

  3. Target weight loss:

    • 0.5 kg/day WITHOUT peripheral edema
    • 1.0 kg/day WITH peripheral edema
    • Exceeding these rates risks plasma volume contraction and renal failure 2

Refractory Ascites Pathway

If ascites persists despite maximum diuretics (spironolactone 400 mg, furosemide 160 mg):

  1. Serial large-volume paracentesis
  2. Evaluate for TIPS candidacy - if suitable, proceed with TIPS
  3. If not TIPS candidate: Assess transplant eligibility
  4. If not transplant candidate: Consider palliative care, indwelling catheter, or alfapump 1

Critical Pitfalls to Avoid

  • Do NOT delay paracentesis for coagulation studies - preprocedure coagulation testing is unnecessary and delays diagnosis 3
  • Do NOT use evening dosing for spironolactone - its long half-life causes nocturia 1
  • Do NOT target aggressive weight loss - exceeding 0.5-1.0 kg/day causes volume depletion 2
  • Do NOT send fluid to lab before inoculating culture bottles - bedside inoculation is mandatory 3
  • Do NOT use urine mode on automated analyzers - body fluid mode is required for accurate cell counts 4

References

5
Research

Laboratory diagnostics of spontaneous bacterial peritonitis.

Clinica chimica acta; international journal of clinical chemistry, 2014

Related Questions

What is the interpretation of a peritoneal fluid analysis showing an elevated RBC count, abnormal white blood cell differential, and elevated protein and glucose levels?
What is the next step in management for a patient with new‑onset moderate ascites whose ascitic fluid analysis shows a total nucleated cell count of 3050 cells/µL with 6% polymorphonuclear leukocytes, 90% lymphocytes, 4% mesothelial cells, total protein 5.6 g/dL, glucose 84 mg/dL, lactate dehydrogenase 381 U/L, ascitic albumin 2.87 g/dL, and serum albumin 3.64 g/dL?
What is the appropriate approach to diagnose peritonitis?
What are the guidelines for interpreting ascitic fluid analysis, including serum‑ascites albumin gradient, total protein, cell count, and additional studies?
In post‑pericardiotomy syndrome, does the peripheral blood complete blood count show an elevated white‑cell count?
How should swelling of the right oral cavity be evaluated and managed?
What is the appropriate palliative external-beam radiation regimen for a patient with urinary bladder cancer metastases to the axilla and the T11 vertebral body?
What is the mechanism of action, recommended dosing, and common side effects of tucatinib (Tukysa) for HER2‑positive metastatic breast cancer?
In a patient 35 days after an allogeneic stem cell transplant who develops hemorrhagic cystitis, what are the appropriate diagnostic workup and treatment options?
What is the appropriate management for a gluteus maximus vascular malformation?
How long does a colonoscopic tattoo remain visible in the colon?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.